Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and ...
Early flooding hits Venice, Fla. Honda recalls nearly 1.7 million vehicles for steering problem that could lead to crashes ...
UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...
GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...
New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, . Sanofi advances its ambition to protect ...
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of ...
The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.
GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...
Some cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...
Explore the significant advancements in early diagnosis and treatment of Gaucher disease, a common lysosomal storage disorder ...
British pharmaceutical company GSK said it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac ...
Kathryn Thomas has reflected on rushing her daughter to the hospital after she contracted RSV at just three weeks old.